Longlasting remissions after treatment with rituximab for autoimmune myositis

Journal of Rheumatology

Volumn 35, Issue 6, 2008, Pages 1230-1232

  Feist, Eugen ^a   Dörner, Thomas ^a   Sörensen, Helmut ^a   Burmester, Gerd R ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE; RITUXIMAB;

ABSENCE OF SIDE EFFECTS; ADULT; CASE REPORT; DERMATOMYOSITIS; DRUG DOSE ESCALATION; DRUG DOSE REDUCTION; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LETTER; MALE; MONOTHERAPY; MUSCLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REMISSION; RHEUMATOID ARTHRITIS;

ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; DERMATOMYOSITIS; DRUG ADMINISTRATION SCHEDULE; HUMANS; MALE; MIDDLE AGED; PARANEOPLASTIC SYNDROMES; TIME; TREATMENT FAILURE;

EID: 44949182713     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (7)

1. Levine TD. Rituximab in the treatment of dermatomyositis: an open-label pilot study. Arthritis Rheum 2005;52:601-7.
2. Noss EH, Hausner-Sypek DL, Weinblatt ME. Rituximab as therapy for refractory polymyositis and dermatomyositis. J Rheumatol 2006;33:1021-6.
3. Chiappetta N, Steier J, Gruber B. Rituximab in the treatment of refractory dermatomyositis. J Clin Rheumatol 2005;11:264-6.
4. Stringer E, Feldman BM. Advances in the treatment of juvenile dermatomyositis. Curr Opin Rheumatol 2006;18:503-6.
5. Ytterberg SR. Treatment of refractory polymyositis and dermatomyositis. Curr Rheumatol Rep 2006;8:167-73.
6. Brulhart L, Waldburger JM, Gabay C. Rituximab in the treatment of antisynthetase syndrome. Ann Rheum Dis 2006;65:974-5.
7. Popa C, Leandro MJ, Cambridge G, Edwards JC. Repeated B lymphocyte depletion with rituximab in rheumatoid arthritis over 7 yrs. Rheumatology Oxford 2007;46:626-30.